Swiss biopharma company to produce Russian Sputnik vaccine in Italy
A Swiss biotech company will manufacture Russia's "Sputnik V" COVID-19 vaccine in facilities across Italy, the firm announced Monday.
Bloomberg News reported that Adienne Pharma & Biotech announced a deal with Russia's sovereign wealth fund, the RDIF, to begin production near Milan. The company aims to have several million doses manufactured by the end of 2021, pending Italian regulatory approval.
Read more...